Lack of transparency, wrongdoings, and unlawful promotion characterize the healthcare industry; these are especially prevalent within the pharmaceutical industry. Consequently, an investigation into the evidence of the corruption and the ethical infringement is needed. In this paper, I will evaluate the pharmaceutical industry’s adherence to the three major branches of ethics. The ever-increasing prices of pharmaceutical products, especially medications used for the combating of anaphylaxis and cancer, coupled with the compensatory-based medication promotion and research points to a major crisis in the realm of social justice. These examples, among many other current issues, lead to difficulties in individuals receiving the medications they truly need, either because they cannot afford them or the information is being withheld. Recent price hikes in medications also raise questions of whether this industry is truly providing for the health needs of all individuals or if it is merely preying on profit-generating opportunities.
"An Ethical Evaluation of the Modern Pharmaceutical Industry,"
Dialogue & Nexus: Vol. 4, Article 9.
Available at: https://digitalcommons.acu.edu/dialogue/vol4/iss1/9
Bioethics and Medical Ethics Commons, Business Law, Public Responsibility, and Ethics Commons, Christianity Commons, Economic Policy Commons, Ethics and Political Philosophy Commons, Health Policy Commons, Inequality and Stratification Commons, Medicine and Health Commons, Other Legal Studies Commons, Other Philosophy Commons, Social Policy Commons, Social Welfare Commons